HCA Healthcare Inc (NYSE:HCA) insider Jonathan B. Perlin sold 25,000 shares of the stock in a transaction that occurred on Monday, June 11th. The stock was sold at an average price of $106.00, for a total transaction of $2,650,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.
Jonathan B. Perlin also recently made the following trade(s):
- On Thursday, May 17th, Jonathan B. Perlin sold 11,520 shares of HCA Healthcare stock. The stock was sold at an average price of $104.00, for a total transaction of $1,198,080.00.
HCA Healthcare traded up $0.16, hitting $105.84, during midday trading on Thursday, according to MarketBeat.com. 67,013 shares of the company’s stock traded hands, compared to its average volume of 2,061,367. HCA Healthcare Inc has a one year low of $71.18 and a one year high of $107.37. The firm has a market cap of $37.18 billion, a PE ratio of 16.07, a PEG ratio of 1.04 and a beta of 0.51. The company has a debt-to-equity ratio of -7.13, a quick ratio of 1.17 and a current ratio of 1.39.
The company also recently declared a quarterly dividend, which will be paid on Friday, June 29th. Stockholders of record on Friday, June 1st will be given a $0.35 dividend. This represents a $1.40 dividend on an annualized basis and a dividend yield of 1.32%. The ex-dividend date is Thursday, May 31st. HCA Healthcare’s dividend payout ratio is 21.24%.
Several large investors have recently added to or reduced their stakes in HCA. M&T Bank Corp raised its position in shares of HCA Healthcare by 11.8% in the fourth quarter. M&T Bank Corp now owns 36,094 shares of the company’s stock valued at $3,170,000 after purchasing an additional 3,803 shares during the period. OLD National Bancorp IN raised its position in shares of HCA Healthcare by 54.8% in the fourth quarter. OLD National Bancorp IN now owns 8,831 shares of the company’s stock valued at $776,000 after purchasing an additional 3,128 shares during the period. Wealthstreet Investment Advisors LLC bought a new position in shares of HCA Healthcare in the fourth quarter valued at approximately $791,000. Buckley Wealth Management LLC bought a new position in shares of HCA Healthcare in the fourth quarter valued at approximately $264,000. Finally, Bronfman E.L. Rothschild L.P. raised its position in shares of HCA Healthcare by 108.0% in the fourth quarter. Bronfman E.L. Rothschild L.P. now owns 2,425 shares of the company’s stock valued at $213,000 after purchasing an additional 1,259 shares during the period. 70.99% of the stock is currently owned by institutional investors.
A number of analysts have recently issued reports on the stock. Zacks Investment Research lowered shares of HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Tuesday, March 20th. Mizuho assumed coverage on shares of HCA Healthcare in a research report on Friday, March 23rd. They issued a “buy” rating and a $115.00 price target for the company. Four investment analysts have rated the stock with a sell rating, six have issued a hold rating and sixteen have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus target price of $105.95.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.